首页> 外国专利> A Humanized Antibody that binds to human CD20 or a fragment thereof, a composition, An article of manufacture a method to induce apoptosis in B cells in vivo, the use of these Antibodies for the manufacture of a Medicament for treating cancer, autoimmune diseases and arthritis Reum

A Humanized Antibody that binds to human CD20 or a fragment thereof, a composition, An article of manufacture a method to induce apoptosis in B cells in vivo, the use of these Antibodies for the manufacture of a Medicament for treating cancer, autoimmune diseases and arthritis Reum

机译:与人CD20或其片段结合的人源化抗体,组合物,在体内诱导B细胞凋亡的制造方法的制品,这些抗体在制备用于治疗癌症,自身免疫性疾病和关节炎的药物中的用途雷姆

摘要

A Humanized Antibody that binds to human CD20 Binding to antigen, or a fragment thereof, where the Antibody is effective in reducing B cells in vivo of primates, including the Antibody variable region of the H Chain (VH) CDr3 sequence of at least one sec. Id.No: 12 a CD20 Antibody anti Human Waste and essentially the Framework (FR) of Human consensus of Human heavy chain Subgroup III (vhiii), a composition, An article of manufacture comprising a Container and a composition comprising the Humanized Antibody that binds to CD2 0, a method for Inducing apoptosis in B cells in vivo.Use of these Antibodies for the manufacture of a Medicament for treating cancer, autoimmune diseases and rheumatoid arthritis, an isolated Nucleic Acid encoding Said Antibody, expression vector, host Cell; a method for producing a CD20 Antibody, Polypeptide Isolated and a Liquid formulation.
机译:结合人CD20的人源化抗体结合抗原或其片段,其中该抗体可有效减少灵长类动物的体内B细胞,包括至少一秒钟的H链(VH)CDr3序列的抗体可变区。 Id.No:12 CD20抗体抗人类废物和实质上是人类重链亚组III(vhiii)的人类共识框架(FR),组合物,包含容器的制品和包含结合人源化抗体的组合物CD2 0为在体内诱导B细胞凋亡的方法。这些抗体在制备用于治疗癌症,自身免疫性疾病和类风湿性关节炎的药物中的用途,所述编码所述抗体的分离的核酸,表达载体,宿主细胞;制备CD20抗体,多肽分离物和液体制剂的方法。

著录项

  • 公开/公告号AR072523A2

    专利类型

  • 公开/公告日2010-09-01

    原文格式PDF

  • 申请/专利权人 GENENTECH INC.;

    申请/专利号AR2009P102739

  • 发明设计人

    申请日2009-07-17

  • 分类号C07K16/18;C07K16/22;C12N15/13;C12N15/63;C12N15/79;A61K39/395;A61P35/00;A61P19/02;A61J1/00;

  • 国家 AR

  • 入库时间 2022-08-21 18:47:32

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号